Market Currents
Celldex Therapeutics (CLDX -11.2%) is pummeled after pricing its offering of 10.5M common shares...
-
Friday, February 24, 2012, 12:51 PM ETCelldex Therapeutics (CLDX -11.2%) is pummeled after pricing its offering of 10.5M common shares at a discounted $3.85 each. CLDX had closed yesterday at $4.36.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
